Published in Ann Neurol on February 01, 1985
Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology (2010) 1.79
Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. J Neurol Neurosurg Psychiatry (2005) 1.75
Olfactory dysfunction in Parkinson disease. Nat Rev Neurol (2012) 1.73
Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J Neurol (2005) 1.65
Olfaction in Parkinson's disease and related disorders. Neurobiol Dis (2011) 1.51
The cholinergic system and Parkinson disease. Behav Brain Res (2010) 1.38
Cholinergic dysfunction in Parkinson's disease. Curr Neurol Neurosci Rep (2013) 0.95
Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease. Acta Neuropathol (2015) 0.89
Hypothesis: microtubules, a key to Alzheimer disease. Proc Natl Acad Sci U S A (1989) 0.88
Profound olfactory dysfunction in myasthenia gravis. PLoS One (2012) 0.87
Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease. CMAJ (1991) 0.86
Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study. Exp Brain Res (2005) 0.84
Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study. J Neurol Neurosurg Psychiatry (1998) 0.82
Neocortical morphometry and cholinergic neurochemistry in Pick's disease. Am J Pathol (1988) 0.82
Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease. Springerplus (2015) 0.82
Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age. J Neurol Neurosurg Psychiatry (1987) 0.81
Memory loss from a subcortical white matter infarct. J Neurol Neurosurg Psychiatry (1988) 0.80
Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment. Cereb Cortex (2015) 0.80
Subcortical afferent projection systems in Huntington's chorea. Acta Neuropathol (1989) 0.78
In vivo AAV-mediated expression of calbindin-D₂₈k in rat basal forebrain cholinergic neurons. J Neurosci Methods (2012) 0.78
The nucleus basalis of Meynert in multi-infarct (vascular) dementia. Acta Neuropathol (1986) 0.78
An update on brain imaging in parkinsonian dementia. Imaging Med (2012) 0.77
Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein. PLoS One (2015) 0.77
Sleep in Alzheimer's Disease - Beyond Amyloid. Neurobiol Sleep Circadian Rhythms (2016) 0.75
The nucleus basalis of Meynert in 20 definite cases of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (1989) 0.75
New MRI Biomarkers Advance the Characterization of Parkinson Disease. Eur Neurol Rev (2013) 0.75
Recent advances in the understanding of dementia. Postgrad Med J (1988) 0.75
Neuropathological study on the nucleus basalis of Meynert in Pick's disease. Acta Neuropathol (1989) 0.75
Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal. J Neural Transm (Vienna) (2017) 0.75
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology (1999) 6.03
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol (1998) 5.93
Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau) Proc Natl Acad Sci U S A (1986) 4.26
Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans. Antimicrob Agents Chemother (1983) 3.46
A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet (1998) 3.41
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology (1995) 2.69
The NIMH Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study: background and methodology. J Am Acad Child Adolesc Psychiatry (1996) 2.43
Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics (1993) 2.39
Effects of telephone versus face-to-face interview modes on reports of alcohol consumption. Addiction (2000) 2.34
Characteristics of women with and without breast augmentation. JAMA (1997) 2.26
Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology (1997) 2.13
A 10-year national trend study of alcohol consumption, 1984-1995: is the period of declining drinking over? Am J Public Health (2000) 2.12
The clinical spectrum of unruptured intracranial aneurysms. Arch Neurol (1993) 2.11
Average volume of alcohol consumption, patterns of drinking, and all-cause mortality: results from the US National Alcohol Survey. Am J Epidemiol (2001) 2.11
Who drinks most of the alcohol in the US? The policy implications. J Stud Alcohol (1999) 1.94
The internal clock: evidence for a temporal oscillator underlying time perception with some estimates of its characteristic frequency. Perception (1990) 1.65
Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol (1999) 1.64
Disposition of radiolabeled imipenem and cilastatin in normal human volunteers. Antimicrob Agents Chemother (1984) 1.63
Reports of alcohol-related harm: telephone versus face-to-face interviews. J Stud Alcohol (2001) 1.61
A modified cluster-sampling method for post-disaster rapid assessment of needs. Bull World Health Organ (1996) 1.60
Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporins. Rev Infect Dis (1989) 1.60
Pathogenesis of IgA1 protease-producing and -nonproducing Haemophilus influenzae in human nasopharyngeal organ cultures. J Infect Dis (1986) 1.58
Interferometric spectroscopy of scattered light can quantify the statistics of subdiffractional refractive-index fluctuations. Phys Rev Lett (2013) 1.51
The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology (1995) 1.51
Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology (1997) 1.44
Prevalence and correlates of harassment among US women physicians. Arch Intern Med (1998) 1.43
Alcoholic beverage choice, risk perception and self-reported drunk driving: effects of measurement on risk analysis. Addiction (1999) 1.39
Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology (1994) 1.37
Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Neurology (1999) 1.37
Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis Assoc Disord (2000) 1.36
The Pregnancy Risk Assessment Monitoring System: design, questionnaire, data collection and response rates. PRAMS Working Group. Paediatr Perinat Epidemiol (1991) 1.32
Pharmacokinetics of ertapenem in healthy young volunteers. Antimicrob Agents Chemother (2002) 1.29
Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease. Brain Res (1997) 1.27
Diet during adolescence and risk of breast cancer among young women. J Natl Cancer Inst (1998) 1.27
Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology (1987) 1.26
Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology (1998) 1.26
Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau. Lancet (1986) 1.25
Social and emotional competence in children of depressed mothers. Child Dev (1993) 1.24
Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol (1996) 1.24
A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol (1989) 1.23
High-performance liquid chromatographic methods for the determination of a new carbapenem antibiotic, L-749,345, in human plasma and urine. J Chromatogr B Biomed Sci Appl (1998) 1.22
Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc Natl Acad Sci U S A (1994) 1.22
Financial cost as an obstacle to hypertension therapy. Am J Public Health (1986) 1.20
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J Neuropathol Exp Neurol (2001) 1.18
Characteristics of respondents and non-respondents from a case-control study of breast cancer in younger women. Int J Epidemiol (2000) 1.18
Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer (1996) 1.15
Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching. J Pharm Biomed Anal (1997) 1.14
Consortium to Establish a Registry for Alzheimer's Disease (CERAD): clinical, neuropsychological, and neuropathological components. Aging (Milano) (1990) 1.14
Recreational physical activity and breast cancer risk among women under age 45 years. Am J Epidemiol (1998) 1.13
End-stage renal disease treatment modality and patients' quality of life. Longitudinal assessment. Am J Nephrol (1986) 1.12
Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Pharm Res (1996) 1.11
Isolation of two strains of Acanthamoeba castellanii from human tissue and their pathogenicity and isoenzyme profiles. J Clin Microbiol (1983) 1.11
Breast and cervical carcinoma mortality among women in the Appalachian region of the U.S., 1976-1996. Cancer (2000) 1.10
U.S. Women Physicians' personal and clinical breast cancer screening practices. J Womens Health Gend Based Med (2000) 1.09
Amylase-binding proteins A (AbpA) and B (AbpB) differentially affect colonization of rats' teeth by Streptococcus gordonii. Microbiology (2003) 1.08
Prenatal and perinatal risk factors for breast cancer in young women. Epidemiology (1997) 1.08
The cone electrode: ultrastructural studies following long-term recording in rat and monkey cortex. Neurosci Lett (1992) 1.08
Determination of MK-0476 in human plasma by liquid chromatography. J Pharm Biomed Anal (1995) 1.06
Stage of breast cancer in relation to body mass index and bra cup size. Int J Cancer (1999) 1.06
Inflammatory meningeal masses of unexplained origin. An ultrastructural and immunological study. J Neuropathol Exp Neurol (1983) 1.05
A beta40 is a major form of beta-amyloid in nonhuman primates. Neurobiol Aging (1997) 1.03
Prevalence of the amylase-binding protein A gene (abpA) in oral streptococci. J Clin Microbiol (1999) 1.02
beta-Amyloid (A beta) deposition in the brains of aged orangutans. Neurobiol Aging (1997) 1.02
Quantitation of simvastatin and its beta-hydroxy acid in human plasma by liquid-liquid cartridge extraction and liquid chromatography/tandem mass spectrometry. J Mass Spectrom (2000) 1.01
Intracerebral Ganglioneuroblastoma with intracytoplasmic microtubular aggregates: case report and ultrastructural study. Ultrastruct Pathol (1982) 1.01
Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol (1999) 1.00
The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series. Arch Neurol (1999) 0.99
Species-specific oligonucleotides for enumeration of Pseudomonas putida F1, Burkholderia sp. strain JS150, and Bacillus subtilis ATCC 7003 in biodegradation experiments. Appl Environ Microbiol (1998) 0.99
Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans. J Clin Pharmacol (1992) 0.99
Menstrual risk factors and early-onset breast cancer. Cancer Causes Control (2000) 0.99
Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects. J Clin Pharmacol (2001) 0.98
Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers. Biopharm Drug Dispos (1997) 0.97
Targeted alteration of real and imaginary refractive index of biological cells by histological staining. Opt Lett (2012) 0.97
Pharmacokinetics of imipenem and cilastatin in volunteers. Rev Infect Dis (1985) 0.97
Sun protection behaviors among African Americans. Ethn Dis (1999) 0.97
Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults. J Clin Pharmacol (2001) 0.96
Montelukast dose selection in 6- to 14-year-olds: comparison of single-dose pharmacokinetics in children and adults. J Clin Pharmacol (1999) 0.96
Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans. Pharm Res (1994) 0.95
Effect of thromboplastin and instrumentation on the prothrombin time test. Clin Lab Haematol (1981) 0.95
Oral colonization and cariogenicity of Streptococcus gordonii in specific pathogen-free TAN:SPFOM(OM)BR rats consuming starch or sucrose diets. Arch Oral Biol (2001) 0.95
Ultrastructure of tuberous sclerosis: cortical tuber and subependymal tumor. Ann Neurol (1981) 0.94
Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann Neurol (1995) 0.93
Continuity of care in hypertension. An important correlate of blood pressure control among aware hypertensives. Arch Intern Med (1988) 0.92
Intracytoplasmic hyaline inclusion bodies in the nerve cells of the hypoglossal nucleus in human autopsy material. Acta Neuropathol (1971) 0.91
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation. Chemotherapy (1991) 0.91
Congenital diencephalic and brain stem damage: neuropathologic study of three cases. Acta Neuropathol (1982) 0.91
Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. Am J Pathol (1994) 0.91
Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile. Drug Metab Dispos (1997) 0.90
Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. I. Descriptive findings. Am J Epidemiol (1992) 0.89
Pharmacokinetics of rizatriptan in healthy elderly subjects. Int J Clin Pharmacol Ther (2001) 0.89
Influence of culture media and environmental factors on mycelial growth and pycnidial production of Sphaeropsis pyriputrescens. Mycologia (2006) 0.89
Neuritic plaque amyloid in Alzheimer's disease is highly racemized. J Neurochem (1988) 0.89
Rapid evolution of central nervous system lymphoma in renal transplant recipient. Lancet (1981) 0.89
Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: an immunohistochemical study. J Neuropathol Exp Neurol (1993) 0.89
Biopharmaceutical evaluation of 'Osmosin'. Curr Med Res Opin (1983) 0.89
Malignant carcinoid causing spinal cord compression. Neurosurgery (1985) 0.89
Employment status and ability to work among working-age chronic dialysis patients. Am J Nephrol (1991) 0.89